Biodesix, Inc.
BDSX
$0.8622
$0.01221.44%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | 30.82% | 32.66% | 31.37% | 20.32% | -8.48% |
Total Depreciation and Amortization | -3.74% | -14.30% | -13.21% | -5.77% | 15.73% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -36.36% | -27.45% | -37.83% | -34.31% | 7.29% |
Change in Net Operating Assets | -256.27% | -268.77% | -145.75% | 360.22% | 462.09% |
Cash from Operations | -152.21% | -72.26% | 22.91% | 49.15% | 47.86% |
Capital Expenditure | 75.42% | 34.61% | -44.48% | -594.94% | -1,052.00% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 0.55% | 6.67% | 13.64% | 39.41% | 36.90% |
Cash from Investing | 74.80% | 34.31% | -43.54% | -552.57% | -907.68% |
Total Debt Issued | -66.67% | -66.67% | -77.78% | -77.83% | 98.65% |
Total Debt Repaid | 99.78% | 99.80% | 99.83% | 99.83% | 5.75% |
Issuance of Common Stock | 19.64% | 90.48% | -50.02% | -52.03% | 65.72% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 65.96% | 40.24% | 56.02% | 45.54% | -21.73% |
Cash from Financing | 50.17% | 146.80% | -45.46% | -50.53% | 288.67% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 147.88% | 321.99% | -255.78% | -261.94% | 114.25% |